Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans

1Ree IMC, Besuden CFJ, Wintjens V, et al. Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome. Vox Sang 2021;116:990–7. Ree IMC Besuden CFJ Wintjens V et al Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome Vox Sang 2021116990 710.1111/vox.13090859639433730387Search in Google Scholar

2Floch A. Maternal Red Blood Cell Alloimmunisation Working Party, literature review. RH blood group system: rare specificities. Transfus Clin Biol 2021;28:314–20. Floch A Maternal Red Blood Cell Alloimmunisation Working Party, literature review RH blood group system: rare specificities. Transfus Clin Biol 202128314 2010.1016/j.tracli.2021.04.00733895380Search in Google Scholar

3Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS One 2020;15:e0235807. Pegoraro V Urbinati D Visser GHA et al Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children PLoS One 202015e023580710.1371/journal.pone.0235807737120532687543Search in Google Scholar

4Gudlaugsson B, Hjartardottir H, Svansdottir G, et al. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis. Transfusion 2020;60:175–83. Gudlaugsson B Hjartardottir H Svansdottir G et al Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis Transfusion 202060175 8310.1111/trf.1563531850521Search in Google Scholar

5Dajak S, Stefanović V, Capkun V. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first–trimester screening (CME). Transfusion 2011;51:1380–8. Dajak S Stefanović V Capkun V Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first–trimester screening (CME) Transfusion 2011511380 810.1111/j.1537-2995.2010.03006.x21214583Search in Google Scholar

6Turley E, McGowan EC, Hyland CA, et al. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion 2018;58:2260–4. Turley E McGowan EC Hyland CA et al Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) Transfusion 2018582260 410.1111/trf.1494430222865Search in Google Scholar

7Bub CB, Aravechia MG, Costa TH, Kutner JM, Castilho L. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization. J Clin Lab Anal 2018;32:e22221. Bub CB Aravechia MG Costa TH Kutner JM Castilho L RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization J Clin Lab Anal 201832e2222110.1002/jcla.22221681698328374955Search in Google Scholar

8Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal 2018;32:e22285. Lukacevic Krstic J Dajak S Bingulac-Popovic J Dogic V Mratinovic-Mikulandra J Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population J Clin Lab Anal 201832e2228510.1002/jcla.22285681708828649781Search in Google Scholar

9Quantock KM, Lopez GH, Hyland CA, et al. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn. Transfusion 2017;57:1938–43. Quantock KM Lopez GH Hyland CA et al Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn Transfusion 2017571938 4310.1111/trf.1415628639307Search in Google Scholar

10Duncan JA, Nahirniak S, Onell R, Clarke G. Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D. Immunohematology 2017;33:60–3. Duncan JA Nahirniak S Onell R Clarke G Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D Immunohematology 20173360 310.21307/immunohematology-2019-009Search in Google Scholar

11Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D antibodies in pregnant D variant antigen carriers initially typed as RhD. Transfus Med Hemother 2016;43:419–24. Lukacevic Krstic J Dajak S Bingulac-Popovic J Dogic V Mratinovic-Mikulandra J Anti-D antibodies in pregnant D variant antigen carriers initially typed as RhD Transfus Med Hemother 201643419 2410.1159/000446816515971227994529Search in Google Scholar

12Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype: College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 2015;55:680–9. Sandler SG Flegel WA Westhoff CM et al It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype: College of American Pathologists Transfusion Medicine Resource Committee Work Group Transfusion 201555680 910.1111/trf.12941435754025438646Search in Google Scholar

13Flegel WA, Denomme GA, Queenan JT, et al. It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855–9. Flegel WA Denomme GA Queenan JT et al It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4 Transfusion 202060855 910.1111/trf.15741912135032163599Search in Google Scholar

14Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol 2017;179:10–9. Sandler SG Chen LN Flegel WA Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype Br J Haematol 201717910 910.1111/bjh.14757561284728508413Search in Google Scholar

15Wagner FF, Flegel WA. The Rhesus Site. Transfus Med Hemother 2014;41:357–63. Wagner FF Flegel WA The Rhesus Site Transfus Med Hemother 201441357 6310.1159/000366176426449225538538Search in Google Scholar

16Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings. Vox Sang 2019;114:95–102. Storry JR Clausen FB Castilho L et al International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings Vox Sang 201911495 10210.1111/vox.12717634265230421425Search in Google Scholar

17Flegel WA. Proceed with care: the “uncommon” serologic weak D phenotypes. Blood Transfus 2021;19:272–6. Flegel WA Proceed with care: the “uncommon” serologic weak D phenotypes Blood Transfus 202119272 6Search in Google Scholar

18International Society of Blood Transfusion. Names for RHD (ISBT 004) Blood Group Alleles (ISBT_004__RHD_blood_ group_alleles_v6.0_30–NOV–2021.pdf). https://www. isbtweb.org/resource/004rhd.html. Accessed 2 February 2022. International Society of Blood Transfusion Names for RHD (ISBT 004) Blood Group Alleles (ISBT_004__RHD_blood_ group_alleles_v6.0_30–NOV–2021.pdf) https://www. isbtweb.org/resource/004rhd.html Accessed 2 February 2022Search in Google Scholar

19Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699–708. Wagner FF Frohmajer A Ladewig B et al Weak D alleles express distinct phenotypes Blood 2000952699 70810.1182/blood.V95.8.2699Search in Google Scholar

20Wagner FF, Ladewig B, Angert KS, Heymann GA, Eicher NI, Flegel WA. The DAU allele cluster of the RHD gene. Blood 2002;100:306–11. Wagner FF Ladewig B Angert KS Heymann GA Eicher NI Flegel WA The DAU allele cluster of the RHD gene Blood 2002100306 1110.1182/blood-2002-01-032012070041Search in Google Scholar

21Flegel WA, von Zabern I, Doescher A, et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion 2009;49:1059–69. Flegel WA von Zabern I Doescher A et al D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters Transfusion 2009491059 6910.1111/j.1537-2995.2009.02102.x19309476Search in Google Scholar

22Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999;94:4337–42. Hemker MB Ligthart PC Berger L van Rhenen DJ van der Schoot CE Wijk PA DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks Blood 1999944337 4210.1182/blood.V94.12.4337Search in Google Scholar

23Yu X, Wagner FF, Witter B, Flegel WA. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion 2006;46:1343–51. Yu X Wagner FF Witter B Flegel WA Outliers in RhD membrane integration are explained by variant RH haplotypes Transfusion 2006461343 5110.1111/j.1537-2995.2006.00902.x16934070Search in Google Scholar

24Horuk R, Martin AW, Wang Z, et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 1997;158:2882–90. Horuk R Martin AW Wang Z et al Expression of chemokine receptors by subsets of neurons in the central nervous system J Immunol 19971582882 9010.4049/jimmunol.158.6.2882Search in Google Scholar

25Huh JY, Park G, Jang SJ, Moon DS, Park YJ. A rapid long PCR-direct sequencing analysis for ABO genotyping. Ann Clin Lab Sci 2011;41:340–5. Huh JY Park G Jang SJ Moon DS Park YJ A rapid long PCR-direct sequencing analysis for ABO genotyping Ann Clin Lab Sci 201141340 5Search in Google Scholar

26Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93. Wagner FF Gassner C Müller TH Schönitzer D Schunter F Flegel WA Molecular basis of weak D phenotypes Blood 199993385 9310.1182/blood.V93.1.385Search in Google Scholar

27Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood 2010;116:2836–8. Fasano RM Monaco A Meier ER et al RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management Blood 20101162836 810.1182/blood-2010-04-279372297459120644109Search in Google Scholar

28Ouchari M, Srivastava K, Döscher A, et al. Serologic and molecular characterization of weak D type 29. Transfusion 2017;57:2542–4. Ouchari M Srivastava K Döscher A et al Serologic and molecular characterization of weak D type 29 Transfusion 2017572542 410.1111/trf.14218561284928671325Search in Google Scholar

29Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662–8. Wagner FF Flegel WA RHD gene deletion occurred in the Rhesus box Blood 2000953662 810.1182/blood.V95.12.3662Search in Google Scholar

30Srivastava K, Polin H, Sheldon SL, et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion 2016;56:2520–31. Srivastava K Polin H Sheldon SL et al The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens Transfusion 2016562520 3110.1111/trf.13739549951727480171Search in Google Scholar

31Flegel WA, Gassner C, Muller TH, Schonitzer D, Schunter F, Wagner FF. The molecular basis of weak D (abstract). Vox Sang 1998;74:15. Flegel WA Gassner C Muller TH Schonitzer D Schunter F Wagner FF The molecular basis of weak D (abstract) Vox Sang 19987415Search in Google Scholar

32Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10. Wagner FF Frohmajer A Flegel WA RHD positive haplotypes in D negative Europeans BMC Genet 200121010.1186/1471-2156-2-103726711495631Search in Google Scholar

33Wolinsky H. A mythical beast: increased attention highlights the hidden wonders of chimeras. EMBO Rep 2007;8:212–4. Wolinsky H A mythical beast: increased attention highlights the hidden wonders of chimeras EMBO Rep 20078212 410.1038/sj.embor.7400918180803917330063Search in Google Scholar

34Körmöczi GF, Dauber EM, Haas OA, et al. Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting. Blood 2007;110: 2148–57. Körmöczi GF Dauber EM Haas OA et al Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting Blood 2007110 2148 5710.1182/blood-2007-01-06810617537994Search in Google Scholar

35Dauber EM, Mayr WR, Hustinx H, et al. Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies. Haematologica 2019;104:632–8. Dauber EM Mayr WR Hustinx H et al Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies Haematologica 2019104632 810.3324/haematol.2018.201293639533830237270Search in Google Scholar

36Lin JJ, Wang XD, Zhu SY. α-1,3-N-acetylgalactose aminotransferase gene 539G>C mutation leads to the A2B isoform. Genet Mol Res 2014;13:2987–93. Lin JJ Wang XD Zhu SY α-1,3-N-acetylgalactose aminotransferase gene 539G>C mutation leads to the A2B isoform Genet Mol Res 2014132987 9310.4238/2014.April.16.724782133Search in Google Scholar

37Reiss RF, Malavade V, Johnson CL, Hendricks E, Rabin BI, Marsh WL. Blood grouping with the Olympus PK7100 testing system. Clin Lab Haematol 1988;10:385–90. Reiss RF Malavade V Johnson CL Hendricks E Rabin BI Marsh WL Blood grouping with the Olympus PK7100 testing system Clin Lab Haematol 198810385 9010.1111/j.1365-2257.1988.tb01185.x3150697Search in Google Scholar

38Saboor M, Zehra A, Hamali HA, et al. Prevalence of A(2) and A(2)B subgroups and anti–A(1) antibody in blood donors in Jazan, Saudi Arabia. Int J Gen Med 2020;13:787–90. Saboor M Zehra A Hamali HA et al Prevalence of A(2) and A(2)B subgroups and anti–A(1) antibody in blood donors in Jazan, Saudi Arabia Int J Gen Med 202013787 9010.2147/IJGM.S272698754823733116770Search in Google Scholar

39Klein HG, Anstee DJ, Eds. ABO, H, LE, P1PK, GLOB, I and FORS blood group systems. In: Mollison’s blood transfusion in clinical medicine. 12th ed. Oxford: Blackwell Publishing Ltd., 2014:121. Klein HG Anstee DJ Eds ABO, H, LE, P1PK, GLOB, I and FORS blood group systems. In: Mollison’s blood transfusion in clinical medicine. 12th ed Oxford Blackwell Publishing Ltd 201412110.1002/9781118689943Search in Google Scholar

40International Society of Blood Transfusion. Names for ABO (ISBT 001) Blood Group Alleles (001_ABO_Alleles_v1.2.pdf). https://www.isbtweb.org/resource/001aboalleles.html. Accessed 2 February 2022. International Society of Blood Transfusion Names for ABO (ISBT 001) Blood Group Alleles (001_ABO_Alleles_v1.2.pdf) https://www.isbtweb.org/resource/001aboalleles.html Accessed 2 February 2022Search in Google Scholar

41Reyes F, Gourdin MF, Lejonc JL, Cartron JP, Gorius JB, Dreyfus B. The heterogeneity of erythrocyte antigen distribution in human normal phenotypes: an immunoelectron microscopy study. Br J Haematol 1976;34:613–21. Reyes F Gourdin MF Lejonc JL Cartron JP Gorius JB Dreyfus B The heterogeneity of erythrocyte antigen distribution in human normal phenotypes: an immunoelectron microscopy study Br J Haematol 197634613 2110.1111/j.1365-2141.1976.tb03608.x791344Search in Google Scholar

42Dogic V, Bingulac-Popovic J, Babic I, et al. Distribution of weak D types in the Croatian population. Transfus Med 2011;21:278–9. Dogic V Bingulac-Popovic J Babic I et al Distribution of weak D types in the Croatian population Transfus Med 201121278 910.1111/j.1365-3148.2011.01071.x21269342Search in Google Scholar

43Flegel WA, Wagner FF, Ó Donghaile DP. Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts. Transfusion 2020;60:1109–10. Flegel WA Wagner FF Ó Donghaile DP Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts Transfusion 2020601109 1010.1111/trf.15788906734932421874Search in Google Scholar

44Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011;44:81–91. Flegel WA Molecular genetics and clinical applications for RH Transfus Apher Sci 20114481 9110.1016/j.transci.2010.12.013304251121277262Search in Google Scholar

45Cornish VW, Kaplan MI, Veenstra DL, Kollman PA, Schultz PG. Stabilizing and destabilizing effects of placing beta-branched amino acids in protein alpha-helices. Biochemistry 1994;33:12022–31. Cornish VW Kaplan MI Veenstra DL Kollman PA Schultz PG Stabilizing and destabilizing effects of placing beta-branched amino acids in protein alpha-helices Biochemistry 19943312022 3110.1021/bi00206a0037918421Search in Google Scholar

46Bruce LJ, Ghosh S, King MJ, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 2002;100:1878–85. Bruce LJ Ghosh S King MJ et al Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex Blood 20021001878 8510.1182/blood-2002-03-070612176912Search in Google Scholar

47Dahl KN, Parthasarathy R, Westhoff CM, Layton DM, Discher DE. Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells. Blood 2004;103:1131–6. Dahl KN Parthasarathy R Westhoff CM Layton DM Discher DE Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells Blood 20041031131 610.1182/blood-2003-04-133114551146Search in Google Scholar

48Nicolas V, Le Van Kim C, Gane P, et al. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J Biol Chem 2003;278:25526–33. Nicolas V Le Van Kim C Gane P et al Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation J Biol Chem 200327825526 3310.1074/jbc.M30281620012719424Search in Google Scholar

49Luettringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D– East Asian persons applied to Korean blood donors. Transfusion 2006;46:2128–37. Luettringhaus TA Cho D Ryang DW Flegel WA An easy RHD genotyping strategy for D– East Asian persons applied to Korean blood donors Transfusion 2006462128 3710.1111/j.1537-2995.2006.01042.x17176325Search in Google Scholar

50Denomme GA, Dake LR, Vilensky D, Ramyar L, Judd WJ. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques. Transfusion 2008;48:473–8. Denomme GA Dake LR Vilensky D Ramyar L Judd WJ Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques Transfusion 200848473 810.1111/j.1537-2995.2007.01551.x18067505Search in Google Scholar

51Tammi SM, Tounsi WA, Sainio S, et al. Next-generation sequencing of 35 RHD variants in 16 253 serologically D– pregnant women in the Finnish population. Blood Adv 2020;4:4994–5001. Tammi SM Tounsi WA Sainio S et al Next-generation sequencing of 35 RHD variants in 16 253 serologically D– pregnant women in the Finnish population Blood Adv 202044994 500110.1182/bloodadvances.2020001569759440333057632Search in Google Scholar

52de Moura Neto JP, Cerqueira BAV, Santos WVB, Lyra IM, Goncalves MS. The DAU allele and anti-D alloimmunization present with high frequency in Brazilian sickle cell disease patients. J Hematol 2017;6:73–80. de Moura Neto JP Cerqueira BAV Santos WVB Lyra IM Goncalves MS The DAU allele and anti-D alloimmunization present with high frequency in Brazilian sickle cell disease patients J Hematol 2017673 8010.14740/jh316w715584732300397Search in Google Scholar

53Karnot A, Woestmann SJ, Flesch BK. Weak RhD phenotype caused by compound heterozygosity for DAU-2 and a new RHD*c393-394 dupGG-mutation (abstract). Transfus Med Hemother 2016;43:42–3. Karnot A Woestmann SJ Flesch BK Weak RhD phenotype caused by compound heterozygosity for DAU-2 and a new RHD*c393-394 dupGG-mutation (abstract) Transfus Med Hemother 20164342 3Search in Google Scholar

54Wagner FF, Moulds JM, Tounkara A, Kouriba B, Flegel WA. RHD allele distribution in Africans of Mali. BMC Genet 2003;4:14. Wagner FF Moulds JM Tounkara A Kouriba B Flegel WA RHD allele distribution in Africans of Mali BMC Genet 200341410.1186/1471-2156-4-1422291214505497Search in Google Scholar

55Kulkarni SS, Gogri H, Parchure D, et al. RHD–positive alleles among D– C/E+ individuals from India. Transfus Med Hemother 2018;45:173–7. Kulkarni SS Gogri H Parchure D et al RHD–positive alleles among D– C/E+ individuals from India Transfus Med Hemother 201845173 710.1159/000479239600660029928172Search in Google Scholar

56Fichou Y, Le Maréchal C, Bryckaert L, et al. A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. Transfusion 2013;53:2974–82. Fichou Y Le Maréchal C Bryckaert L et al A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes Transfusion 2013532974 82Search in Google Scholar

57Heilig EA, Gutti U, Tai T, Shen J, Kelleher RJ 3rd. Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production. J Neurosci 2013;33:11606–17. Heilig EA Gutti U Tai T Shen J Kelleher RJ 3rd Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production J Neurosci 20133311606 1710.1523/JNEUROSCI.0954-13.2013372454923843529Search in Google Scholar